Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Design and synthesis of gallocyanine inhibitors of DKK1/LRP6 interactions for treatment of Alzheimer's disease.

Bioorg. Chem.. 2018; 
ThysiadisSavvas,KatsamakasSotirios,MpousisSpyros,AvramidisNicolaos,EfthimiopoulosSpiros,SarliVasi
Products/Services Used Details Operation
Recombinant Proteins Following washing with TBS-T, proteins were detected by chemiluminescence using the enhanced chemiluminescence system (GenScript Piscataway, NJ, USA) on a Fluorochem 8800 imaging station (AlphaInnotech, CA, USA). Get A Quote

摘要

Based on NCI8642, a series of gallocyanine derivatives was synthesized with modifications of the substituent groups in position 1, 2 and 4 of the phenoxazinone scaffold. The effectiveness of gallocyanines to inhibit DKK1/LRP6 interactions and Tau phosphorylation induced by prostaglandin J2 and DKK1 was elucidated by both experimental data and molecular docking simulations. Bis-alkylated with flexible alkyl ester groups on C1 and bis-benzyl gallocyanines provided the most active inhibitors, while amino derivatives on C2 of NCI8642 that have alkoxy or benzyloxy substituents on C4, were less active. Furthermore, it is shown that treating of SHSY5Y cells with NCI8642 derivatives activates Wnt signaling an... More

关键词

Alzheimer’s disease,DKK1/LRP6 interactions,Gallocyanine derivatives,Phenoxazinone,Tau phosphoryla
XML 地图